These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1535071)

  • 21. Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci.
    Sweeney D; Stoneburner A; Shinabarger DL; Arhin FF; Belley A; Moeck G; Pillar CM
    J Antimicrob Chemother; 2017 Feb; 72(2):622-624. PubMed ID: 27856721
    [No Abstract]   [Full Text] [Related]  

  • 22. The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.
    Seibert G; Isert D; Klesel N; Limbert M; Markus A; Schrinner E
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():25-30. PubMed ID: 1601753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog.
    Zurenko GE; Yagi BH; Vavra JJ; Wentworth BB
    Antimicrob Agents Chemother; 1988 Feb; 32(2):216-23. PubMed ID: 2966608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From the Centers for Disease Control and Prevention. Assessment of testing for and completeness of reporting of vancomycin-resistant enterococci--Connecticut, 1994.
    JAMA; 1996 May; 275(18):1397. PubMed ID: 8618356
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro activity of vancomycin and daptomycin against clinical isolates of Staphylococcus aureus and enterococci from India.
    Jain S; Gaind R; Chugh TD
    Int J Antimicrob Agents; 2013 Jul; 42(1):94-5. PubMed ID: 23611307
    [No Abstract]   [Full Text] [Related]  

  • 26. Antimicrobial susceptibility of enterococci in Thailand from 2000 to 2005.
    Sangsuk L; Dejsirilert S; Sawanpanyalert P; Aswapokee N; Jariyasethpong T
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S1-7. PubMed ID: 21298842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proficiency of clinical laboratories in and near Monterrey, Mexico, to detect vancomycin-resistant enterococci.
    McDonald LC; Garza LR; Jarvis WR
    Emerg Infect Dis; 1999; 5(1):143-6. PubMed ID: 10081682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low carriage of vancomycin-resistant enterococci in the digestive tract of French hospitalised patients: a nationwide prospective study in 2006.
    Fortineau N; Bourdon N; Leclercq R; Vachée A; Delarbre JM; Maugat S; Robert J;
    J Hosp Infect; 2011 Feb; 77(2):179-81. PubMed ID: 21216037
    [No Abstract]   [Full Text] [Related]  

  • 29. Vancomycin resistant enterococci: impact and management in pediatrics.
    Green M
    Adv Pediatr Infect Dis; 1997; 13():257-77. PubMed ID: 9544315
    [No Abstract]   [Full Text] [Related]  

  • 30. Vancomycin-resistant enterococci isolates from the rumen content of deer.
    Lauková A
    Microbios; 1999; 97(387):95-101. PubMed ID: 10453484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vancomycin-resistant Enterococcus spp isolated from community acquired infections and colonizations in Querétaro City, Mexico.
    Garcia-G MC; Leo-Amador GE; Avila-Morales J; Zaldívar-Lelo de Larrea G; Sanchez-Corona J
    Am J Infect Control; 2014 May; 42(5):578-80. PubMed ID: 24773802
    [No Abstract]   [Full Text] [Related]  

  • 32. Bloodstream infections with vancomycin-resistant enterococci.
    Montecalvo MA; Shay DK; Patel P; Tacsa L; Maloney SA; Jarvis WR; Wormser GP
    Arch Intern Med; 1996 Jul; 156(13):1458-62. PubMed ID: 8678715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poultry as a vector for emerging multidrug resistant Enterococcus spp.: First report of vancomycin (van) and the chloramphenicol-florfenicol (cat-fex-cfr) resistance genes from pigeon and duck faeces.
    Osman KM; Badr J; Orabi A; Elbehiry A; Saad A; Ibrahim MDS; Hanafy MH
    Microb Pathog; 2019 Mar; 128():195-205. PubMed ID: 30615998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vancomycin-resistant enterococci].
    Kalenić S; Plecko V; Senji P; Tripković V; Jelić I; Vegar V; Dadić D; Boduen Z
    Lijec Vjesn; 1997 Nov; 119(10):298. PubMed ID: 9531765
    [No Abstract]   [Full Text] [Related]  

  • 35. Nitrofurantoin is active against vancomycin-resistant enterococci.
    Zhanel GG; Hoban DJ; Karlowsky JA
    Antimicrob Agents Chemother; 2001 Jan; 45(1):324-6. PubMed ID: 11120989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci.
    Itokazu GS; Nathan C; Hariharan R; Kostman JR; Kabins SA; Weinstein RA
    Chemotherapy; 1996; 42(4):235-9. PubMed ID: 8804789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin-resistant enterococci in hemodialysis patients is related to intravenous vancomycin use.
    Fishbane S; Cunha BA; Mittal SK; Ruggian J; Shea K; Schoch PE
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):461-2. PubMed ID: 10432156
    [No Abstract]   [Full Text] [Related]  

  • 38. [Vancomycin resistant enterococci].
    Fujita N; Komori T; Ike Y; Yoshimura M
    Rinsho Byori; 1998 Jul; 46(7):629-36. PubMed ID: 9721528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin-dependent enterococcus.
    Rossney AS; McConkey SJ; Keane CT
    Lancet; 1997 Feb; 349(9049):430. PubMed ID: 9033488
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.